Skip to main content

Table 5 Adherence to Follow-Up Among Patients with a Negative Baseline Screen

From: Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up

Lung-RADS 1

 

Black Patients

n = 85

White Patients

n = 97

p-value

Mean Age ± SD

63.8 ± 5.7

64.7 ± 6.0

0.287

Sex

• Female

54 (63.5%)

43 (44.3%)

0.010

• Male

31 (36.5%)

54 (55.7%)

Overall adherencea, n (%)

15 (17.6%)

19 (19.6%)

0.738

Time to follow-up CTb, mean mos ± SD

13.3 ± 1.0

12.9 ± 2.2

0.493

Timely adherencec, n (%)

5 (33.3%)

11 (57.9%)

0.154

Lung-RADS 2

 

Black Patients

n = 81

White Patients

n = 144

p-value

Mean Age ± SD

63.7 ± 6.2

63.8 ± 6.0

0.922

Sex

• Female

56 (69.1%)

73 (51.0%)

0.008

• Male

25 (30.9%)

70 (49.0%)

Overall adherencea, n (%)

17 (21.0%)

30 (20.8%)

0.978

Time to follow-up CTb, mean mos ± SD

15.3 ± 4.8

12.7 ± 2.3

0.015

Timely adherencec, n (%)

4 (23.5%)

11 (57.9%)

0.002

  1. a Overall adherence was defined as any follow-up CT chest following the baseline LDCT
  2. b Time to follow-up was measured among screened patients who were adherent with any follow-up CT
  3. c On-time adherence was defined as a follow-up CT within 30 days of the recommended time-frame for follow-up (13 months for Lung-RADS 1 or 2)